Acute Renal Failure

Nephrology
1
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Pfizer
PfizerNEW YORK, NY
1 program
1
Standard dose of dialysisPhase 31 trial
Active Trials
NCT00561431Completed200Est. Nov 2007
Fresenius Kabi
Fresenius KabiGermany - Bad Homburg
1 program
calorie restrictionN/A1 trial
Active Trials
NCT01534364Completed82Est. Feb 2015

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
PfizerStandard dose of dialysis
Fresenius Kabicalorie restriction

Clinical Trials (2)

Total enrollment: 282 patients across 2 trials

NCT00561431PfizerStandard dose of dialysis

High Dose CVVHDF Compared to Standard Dose CVVHDF

Start: Jul 2003Est. completion: Nov 2007200 patients
Phase 3Completed
NCT01534364Fresenius Kabicalorie restriction

Brief Title:Effect of a Preoperative Calorie Restriction on Renal Function After Cardiac Surgery

Start: Jan 2012Est. completion: Feb 201582 patients
N/ACompleted

Related Jobs in Nephrology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 late-stage (Phase 3) programs — potential near-term approvals
2 companies competing in this space